Aigen Investment Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$50.1K	Buy	+14,730	New	+$50.1K	0.01%	745
2023 Q1	–	Sell	-14,102	Closed	-$144K	–	661
2022 Q4	$144K	Buy	+14,102	New	+$144K	0.02%	480